This isn't an example of SAVA vs AVXL, but instead a demonstration of how Seeking Alpha is pitched at the most superficial level of scientific analysis, and how its editors were, and its readership would be, utterly bewildered by any in-depth, professional-level biotech discussion. In short, it is a display of SA's worthlessness to serious investors.
News 
Market Data 
Discover 
